Por: The Hill Health June 27, 2023
Pfizer announced Monday it was discontinuing the development of one of its obesity pill candidates due to elevated levels of liver enzymes being detected during clinical trials, while the development of another obesity pill is set to continue. The pharmaceutical company has been developing two oral treatments for treating obesity and Type 2 diabetes mellitus: danuglipron and lotiglipron. The drug also garnered heightened attention earlier this... + full article
Portland Press Herald USA World June 27, 2023
Struggling to recover from waning coronavirus vaccine demand, Pfizer is racing to catch up with Novo Nordisk and Eli Lilly in an obesity-treatment market. Bloomberg photo by Stephanie Keith Pfizer shares fell after the company halted early development of an oral drug for weight... + más
Obesity in 2035 could be just as costly as COVID in 2020 | WPTV
Half Of Global Population Will Be Overweight In 12 Years: Study | RTTNews
Time USA Science June 26, 2023
shares fell after it halted early development of an oral drug for on safety concerns, raising investor anxiety about an alternative therapy the company is still developing. The drugmaker will stop work on lotiglipron based on data from phase 1 clinical trials and lab... + más
WPTV USA Nation March 04, 2023
The global economic impact of obesity in 2035 is expected to be comparable to that of COVID-19 in 2020, according to a new report by the World Obesity Federation. half of the world’s population will either be considered overweight or obese by 2035. Even more concerning,... + más
‘Worrying’ global obesity projections for 2035 revealed in new report | New York Post
RTTNews USA Health March 03, 2023
More than half the global population will be living with overweight and obesity within 12 years if prevention, treatment and support do not improve, says a global study conducted by the World Obesity Federation.The World Obesity Atlas 2023, published ahead of World Obesity Day,... + más
World’s fattest countries revealed: Where does America fall on the list? | New York Post
Forbes USA Business January 24, 2023
Ginkgo Bioworks banner on the façade of the New York Stock Exchange building.Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its versatile menu of biology engineering services. As a full-stack synthetic biology service... + más
Ginkgo Bioworks buys two small biotech companies | The Boston Globe
Ginkgo is trying to detect future man-made biological threats | The Boston Globe
Orlando Sentinel USA Business January 09, 2023
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting,” or... + más
New guidance: Use drugs, surgery early for obesity in kids | ABC News
ABC News USA Health January 09, 2023
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting, or... + más
Use drugs and surgery early for obesity in kids, new guidance says | Orlando Sentinel
About iurex | Privacy Policy | Disclaimer |